Cosmos Health raises $32.5M in registered direct offering and private placement at $11.50/unit

Cosmos Health Inc.

Gross proceeds of ~$32.5M from sale of 2,828,320 shares and warrants at $11.50/unit.
Each warrant exercisable immediately at $11.50, expires in 5 years; CEO Siokas participated.
Net proceeds to be used for working capital and general corporate purposes.
A.G.P./Alliance Global Partners sole placement agent; cash fee of 6.5%.

Key facts

Extracted from this filing and checked against the source text.

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.9

Cosmos Health Inc. entered into Securities Purchase Agreement with certain institutional investors valued at $32,525,680 (effective 2022-12-19).

Action: entry
Agreement: equity purchase
Counterparty: certain institutional investors
Value: $32,525,680
Effective: 2022-12-19

Exact text from the filing

On December 19, 2022, Cosmos Health Inc. (“we,” “our,” “us,” or the “Company”) entered into a Securities Purchase Agreement (the “Purchase Agreement”) with certain institutional investors (the “Purchasers”), for a registered direct offering and a concurrent private placement.

View on SEC.gov

38 material agreements filed in the last 30 days. Browse all material agreements →

Cosmos Health Inc. filing history →

Source: SEC EDGAR

accession 0001477932-22-009427

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.